Marinus Pharmaceuticals, Inc.
Ganaxolone for use in treatment of status epilepticus
Last updated:
Abstract:
This invention relates to methods for treating status epilepticus by administering to the subject in need thereof an intravenous bolus of ganaxolone and a continuous intravenous infusion of a neurosteroid. The method provides SE suppression and continued suppression of SE.
Status:
Grant
Type:
Utility
Filling date:
26 Feb 2021
Issue date:
7 Sep 2021